MIPS Molecular Imaging Program at Stanford

Heike Daldrup-Link

Publication Details

  • Macromolecular contrast medium (feruglose) versus small molecular contrast medium (gadopentetate) enhanced magnetic resonance imaging: differentiation of benign and malignant breast lesions.

    Daldrup-Link HE, Kaiser A, Helbich T, Werner M, Bjørnerud A, Link TM, Rummeny EJ. Acad Radiol. 2003; 10 (11): 1237-46

    To compare the diagnostic performance of the blood pool agent feruglose and the standard extracellular contrast agent gadopentetate in their abilities to differentiate benign and malignant breast tumors.

    PubMedID: 14626298

Stanford Medicine Resources:

Footer Links: